Stocks To Buy Now

Blog


DGE 3rd Investigator Initiated Trials Summit 2023: Unlocking Innovations in Pharma Research and Collaboration

The 3rd Investigator Initiated Trials Summit will be held on November 13-14, 2023 in Philadelphia. The DGE event is focused on exploring the most lucrative ways for reviewing, selecting, and funding research investigators. Researchers, medical officers, health and pharma executives and companies can harness the reach and network of the DGE platform to connect with industry stalwarts and discuss vital issues on how they effectively manage IITs.

The speakers will offer important insights on ways to leverage the new methods for new indications, label expansion and potential publications. The conference aims to create a bridge between pharma suppliers and sponsors who are providing vital data and real-world evidence while remaining compliant.

The event is organized by Dynamic Global Events (“DGE”), the leading life science B2B event organizer. This event can be accessed in person and will be streamed live on a trusted interactive platform. Thought leaders, pharma professionals, researchers and leading pharma from across the spectrum will attend to discuss informative topics and form networking connections.

Key Topics Of Discussion:

  • Ways to manage costs, design contracts, and budgetary negotiations
  • Gear up resources to reach out to remote and small-population segments
  • Training and maintaining the best team to improve compliance and communications for the research trials
  • Discussing the role of MSLs in IITs
  • Discussing Collaborative Studies vs. Traditional IITs/IIRs
  • Securing operational support and valuing the well-trained admins

To know more, please visit https://ibn.fm/AOeXP

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Advances Remote Cardiac Diagnostics with HeartNexus Partnership

November 13, 2025

HeartBeam (NASDAQ: BEAT), a medical-technology company developing next-generation cardiac diagnostics via its patented 12-Lead ECG synthesis software, has announced a strategic collaboration with HeartNexus (https://ibn.fm/yyz1i). The partnership will expand access to cardiologist-level ECG insights for arrhythmia assessment anytime, anywhere. Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths […]

Rotate your device 90° to view site.